GERD (acid reflux) Board decisions

The Board denied service connection for irritable bowel syndrome, as the evidence did not support a finding that it began during active service or was related to an in-service injury. The claims for GERD and OSA were remanded for further development.

The Board denied an initial rating in excess of 10 percent for gastroesophageal reflux disease (GERD) as the Veteran's symptoms did not result in considerable impairment of health.

The Board remands the claim for service connection for GERD to correct pre-decisional duty to assist errors.

The Board remands the claims for a rating in excess of 10 percent for GERD and service connection for chest pain, fatigue, and shortness of breath due to COVID-19 to correct duty-to-assist errors.

The Board remands the Veteran's claim for a disability evaluation in excess of 10 percent for hiatal hernia and GERD due to insufficient evidence regarding flare-ups, functional loss, and ameliorative effects of medication.

The Board denied service connection for hemorrhoids and remanded claims for service connection for gastroesophageal reflux disease, hypertension, irritable bowel syndrome, and an initial rating in excess of 70 percent for posttraumatic stress disorder.

The Board denied service connection for hemorrhoids and remanded claims for service connection for gastroesophageal reflux disease, hypertension, irritable bowel syndrome, and an initial rating in excess of 70 percent for posttraumatic stress disorder.

The Board denied service connection for hemorrhoids and remanded claims for service connection for gastroesophageal reflux disease, hypertension, irritable bowel syndrome, and an initial rating in excess of 70 percent for posttraumatic stress disorder.

The Board remands the claim for an initial rating in excess of 30 percent for service-connected irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD) to schedule a VA examination to determine the current severity of the disability without the use of medication.

The Board remands the claims for service connection for GERD and erectile dysfunction, as secondary to service-connected disabilities, for additional development of the record.

The Board granted an effective date of August 3, 2012, for the award of a 10 percent rating for gastroesophageal reflux disease (GERD).

The Board granted service connection for gastroesophageal reflux disease (GERD) as secondary to the Veteran's service-connected musculoskeletal disabilities, but remanded the claim for diabetes mellitus type II due to insufficient evidence.

The Board granted an effective date of July 27, 1993, for the award of service connection for GERD but remanded the issue of entitlement to an initial evaluation in excess of 10 percent for GERD.

The Board granted a disability rating of 60 percent for gastroesophageal reflux disease (GERD), finding that the Veteran's symptoms more nearly approximated severe impairment of health.

The Board denied a compensable rating for GERD prior to March 17, 2022, and a rating greater than 10 percent thereafter.

The Board granted an initial disability evaluation of 30 percent for GERD, denied a compensable evaluation for left ear hearing loss, denied service connection for right ear hearing loss, and denied an increased rating for tinnitus.

The Board granted service connection for left ear hearing loss and GERD, assigned a rating of 20 percent for the back disability from March 31, 2021, and denied service connection for right ear hearing loss, obstructive sleep apnea, and a higher rating for the right shoulder disability.

The Board remands the claims for service connection for GERD and sleep apnea to obtain additional medical opinions addressing secondary service connection, including the effects of medication.

The Board remands the claim for an evaluation in excess of 10 percent for gastroesophageal reflux disease (GERD) to obtain outstanding private treatment records.

The Board denied a compensable rating for hypertension and granted a 70 percent disability rating for PTSD prior to January 17, 2024, while denying an increased rating on and after that date. The issues related to the lumbar strain and GERD were remanded.